drugset / Trial / NCT01499485

Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.

NCT01499485

Phase 3 Completed 140 enrolled Hospital Son Llatzer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to analyze whether the treatment of metabolic alkalosis with acetazolamide in intubated patients with chronic obstructive pulmonary disease (COPD) or with obesity hypoventilation syndrome (OHS) reduces the length of mechanical ventilation (MV).

Timeline

Start
2011-11
Primary completion
2015-02
Completion
2015-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 500 mg Other